UPPCRN-RCT#1: Physical Therapy Trial for Pelvic Pain

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
Overall Status
Completed
CT.gov ID
NCT00434343
Collaborator
(none)
48
5
12
9.6
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if a randomized trial of physical therapy for pelvic pain is feasible.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Physical Therapy
N/A

Detailed Description

This is a pilot study wherein eligible participants will be randomly assigned to receive either myofascial tissue manipulation or global therapeutic massage. Those receiving myofascial tissue manipulation will have targeted internal and external connective tissue manipulation focusing on the muscles and connective tissues of the pelvic floor, hip girdle, and abdomen. Those receiving global therapeutic massage will have non-specific somatic treatment with full-body Western massage.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
A Pilot Feasibility Study of Physical Therapy for the Treatment of Urologic Pelvic Pain Syndromes
Study Start Date :
Nov 1, 2006
Actual Primary Completion Date :
Nov 1, 2007
Actual Study Completion Date :
Nov 1, 2007

Outcome Measures

Primary Outcome Measures

  1. number consenting to join study out of eligible patients approached []

  2. number thought eligible by physician deemed ineligible by PT []

  3. adherence to prescribed therapeutic protocol []

  4. adverse events []

  5. tolerability of treatment as rated by patient []

  6. global response assessment []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • female and male patients who have failed to respond to previous therapies for interstitial cystitis/painful bladder syndrome

  • male patients who have failed to respond to previous therapies for chronic prostatitis/chronic pelvic pain syndrome

Exclusion Criteria:
  • neurologic disorder affecting bladder

  • bladder cancer, prostate cancer, or urethral cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Medical Center Stanford California United States 94305
2 Northwestern University Feinberg School of Medicine Chicago Illinois United States 60611
3 Loyola University Medical Center Maywood Illinois United States 60153
4 William Beaumont Hospital Royal Oak Michigan United States 48073
5 Cleveland Clinic Foundation Cleveland Ohio United States 44195

Sponsors and Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Study Director: John Kusek, PhD, National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health
  • Study Director: Leroy Nyberg, PhD, MD, National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00434343
Other Study ID Numbers:
  • DK65209B (IND)
First Posted:
Feb 13, 2007
Last Update Posted:
Mar 3, 2010
Last Verified:
Mar 1, 2010

Study Results

No Results Posted as of Mar 3, 2010